Surmodics, Inc. (SRDX) financial statements (2023 and earlier)

Company profile

Business Address 9924 W 74TH ST
EDEN PRAIRIE, MN 55344
State of Incorp. MN
Fiscal Year End September 30
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
TTM
9/30/2021
9/30/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments32,34331,15330,78530,36123,31848,33646,941
Cash and cash equivalents26,65031,15330,78530,36123,31816,53424,987
Short-term investments5,693    31,80221,954
Restricted cash and investments    350  
Receivables9,92611,08110,0669,55110,0297,8107,566
Inventory, net of allowances, customer advances and progress billings8,2906,7605,9664,5014,0163,5163,579
Inventory8,2906,7605,9664,5014,0163,5163,579
Prepaid expense2,9721,712     
Other undisclosed current assets11,38519,54939,79137,00743,8141,221472
Total current assets:64,91670,25586,60881,42081,52760,88358,558
Noncurrent Assets
Property, plant and equipment29,31930,09030,10329,74830,14322,94219,601
Intangible assets, net (including goodwill)80,13882,66040,46840,39744,71547,84449,080
Goodwill44,90045,60627,18526,17127,03227,28226,555
Intangible assets, net (excluding goodwill)35,23837,05413,28314,22617,68320,56222,525
Deferred income tax assets6,3725,8677,315 
Other noncurrent assets4,1213,7184,2692,1241,446897628
Other undisclosed noncurrent assets 2,002 6,1766,3044,0275,027
Total noncurrent assets:119,950124,33782,15578,44582,60875,71074,336
TOTAL ASSETS:184,866194,592168,763159,865164,135136,593132,894
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities11,21315,16813,69211,45614,4468,0538,149
Accounts payable1,8451,7831,5152,0852,5462,3961,622
Accrued liabilities6,0764,9055,5474,7906,2651,8351,109
Employee-related liabilities3,2928,4806,6304,5815,6353,8225,418
Deferred revenue4,4304,6475,2005,553
Debt10,00010,000     
Business combination, contingent consideration, liability   3,20011,0411,750925
Deferred revenue and credits 180
Other undisclosed current liabilities    9,646 881
Total current liabilities:25,64329,81518,89220,20935,1339,80310,135
Noncurrent Liabilities
Liabilities, other than long-term debt22,55224,69218,81617,1409,14515,23315,926
Deferred revenue and credits 188
Deferred revenue9,29210,30110,79611,628
Deferred income tax liabilities2,5472,742  
Other liabilities10,71311,6498,0205,5125,7202,1192,146
Business combination, contingent consideration, liability    3,42513,11413,592
Other undisclosed noncurrent liabilities    11,247  
Total noncurrent liabilities:22,55224,69218,81617,14020,39215,23315,926
Total liabilities:48,19554,50737,70837,34955,52525,03626,061
Stockholders' equity
Stockholders' equity attributable to parent136,671140,085131,055122,516108,610111,557106,833
Common stock699695684675670655660
Additional paid in capital22,64421,59815,36910,7407,6075,4136,754
Accumulated other comprehensive income751,7273,1743962,7183,4171,273
Retained earnings113,253116,065111,828110,70597,615102,07298,146
Total stockholders' equity:136,671140,085131,055122,516108,610111,557106,833
TOTAL LIABILITIES AND EQUITY:184,866194,592168,763159,865164,135136,593132,894

Income statement (P&L) ($ in thousands)

12/31/2021
TTM
9/30/2021
9/30/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
Revenues105,842105,13694,864100,07781,33673,11271,366
Revenue, net64,57764,202
Cost of revenue(21,260)(19,973)(17,535)(15,883)(22,266)(13,714)(13,330)
Cost of goods and services sold(17,931)(17,177)(15,317)(13,639)(13,997)(11,422)(10,908)
Gross profit:84,58285,16377,32984,19459,07059,39858,036
Operating expenses(81,413)(78,460)(78,580)(77,725)(67,869)(52,295)(41,177)
Operating income (loss):3,1696,703(1,251)6,469(8,799)7,10316,859
Nonoperating income (expense)(235)(357)(203)1,0891,267(70)89
Investment income, nonoperating1081236561,09785139063
Foreign currency transaction gain (loss), before tax43(170)(248)134239(504)(481)
Interest and debt expense(386)(310)(133)(152)   
Income (loss) from continuing operations before equity method investments, income taxes:2,5486,036(1,587)7,406(7,532)7,03316,948
Other undisclosed income from continuing operations before income taxes386310133152   
Income (loss) from continuing operations before income taxes:2,9346,346(1,454)7,558(7,532)7,03316,948
Income tax expense (benefit)(1,235)(2,109)2,577343,075(3,107)(6,963)
Net income (loss) available to common stockholders, diluted:1,6994,2371,1237,592(4,457)3,9269,985

Comprehensive Income ($ in thousands)

12/31/2021
TTM
9/30/2021
9/30/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
Net income (loss):1,6994,2371,1237,592(4,457)3,9269,985
Other comprehensive income (loss)(4,931)(1,447)2,778(2,322)(699)2,1441,268
Comprehensive income (loss), net of tax, attributable to parent:(3,232)2,7903,9015,270(5,156)6,07011,253

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: